Topix Pharmaceuticals, Inc. has announced the launch of GlycolixGlyco-Urea KP Therapy. This new advanced formula helps to treat severely dry skin often associated with skin conditions such as keratosis pilaris (KP), psoriasis, and dermatitis.
Thickened, cracked, itchy skin or skin plaques frequently materialize with unwanted dry skin conditions. Whether intrinsic or extrinsic, factors may strip the skin of natural amino acids and lipids, exposing skin to damage, and potentially leading to inflammation and irritation. The patented technology in KP Therapy has the ability to exfoliate dead skin cells comparable to 40% Urea, while moisturizing and replenishing the skin barrier.
Incorporating the latest generation of exfoliating and nourishing ingredient systems at high concentrations, this breakthrough treatment contains:
Patient assessments in a clinical study revealed results after only 4 weeks:
86% of patients agreed
"Topix's Glyco-Urea cream works like a charm for KP," says Dr. Payam Saadat, dermatologist in Burbank, California. "Both male and female patients love the elegance of the cream and rave about the results."
Results from Glycolix KP Therapy are further complemented when used in a daily skin care regimen. Topix Pharmaceuticals skin care is available through physician offices nationwide and select authorized online retailers.
About Topix Pharmaceuticals
For over 35 years, Topix Pharmaceuticals, Inc., a leader in Micro-Branded skin care innovations, has developed products using the highest quality, pharmaceutical grade ingredients, to provide patients with safe and effective results.
© 2018 BeautyWorldNews.com All rights reserved. Do not reproduce without permission.